BIOMARIN PHARMACEUTICAL INC

Q4 2021 13F Holders

CUSIP
09061GAK7
Type
Debt
Class
NOTE 1.250% 5/1
Num filings
35
Total reported value, excl. options
$480 M
Manager Report Date Value ($000) Principal Option Type